Table 5.

Hemorrhagic complications during 3-month follow up

Items	Intracoronary prourokinase group (N = 25)	Control group (N = 25)	P value
Intracranial hemorrhage, No. (%)	0 (0.0)	0 (0.0)	–
Hematemesis, No. (%)	0 (0.0)	0 (0.0)	–
Hemoptysis, No. (%)	0 (0.0)	0 (0.0)	–
Hematuria, No. (%)	0 (0.0)	0 (0.0)	–
Dermatorrhagia, No. (%)	1 (4.0)	0 (0.0)	1.000
Hemorrhage of puncture site, No. (%)	0 (0.0)	0 (0.0)	–
Gingival bleeding, No. (%)	2 (8.0)	1 (4.0)	1.000

Differences between two groups were determined by Fisher’s exact test